Latest News
Network International reaffirms earnings and revenue guidance
Network International on Wednesday reaffirmed its annual revenue and earnings guidance as the company reported that it had continued to build on a strong first half performance in its third quarter.
Next valuation 'up with events', says Liberum
Liberum downgraded its recommendation on shares of Next to 'hold' from 'buy' on Wednesday as it argued that the stock's valuation is now up with events.
US private sector adds more jobs than expected in October - ADP
Private sector employment in the US rose more than expected in October, according to figures released on Wednesday by ADP.
Europe midday: Markets mixed ahead of Fed rate decision
European stocks were mixed at lunchtime on Wednesday as investors geared up for a Federal Reserve policy announcement later in the day and eyed the latest news on progress in Sino-US trade talks.
Asia report: Markets fall as investors look to Fed rate decision
Markets in Asia were in the red on Wednesday, as investors closed their wallets ahead of the Federal Reserve’s latest interest rate decision, due later in the global day.
GE beats on Q3 earnings, renewable energies unit enjoys favourable wind
General Electric posted better than expected earnings and revenues for the latest three-month stretch, despite the multiple headwinds that it faced during the quarter and as it moved to make the company leaner and bulk up its balance sheet.
De La Rue tumbles after profit warning
Shares of De La Rue tumbled on Wednesday as the banknote printer warned on profits.
London midday: Stocks steady as StanChart rallies, Next slumps
London stocks had flattened out by midday on Wednesday as investors mulled the prospect of a general election before Christmas and sifted through updates from the likes of Next and Standard Chartered.
Roche clears EMA hurdle for 'satralizumab'
Roche announced on Wednesday that the European Medicines Agency (EMA) has validated its marketing authorisation application for ‘satralizumab’, for the treatment of adult and adolescent patients with neuromyelitis optica spectrum disorder (NMOSD), granting it ‘accelerated assessment’.
Sports Direct says CMA figures 'wrong' in Footasylum probe
Sports Direct International issued a response to a Competition and Markets Authority (CMA) decision to refer the completed acquisition by JD Sports Fashion of Footasylum to a phase 2 investigation on Wednesday.
Petra Diamonds reassures shareholders after incident at Cullinan
Petra Diamonds announced on Wednesday that there has been a scaling of the open pit wall at the Cullinan mine in South Africa, following a thunderstorm over the weekend.
Argo Blockchain doubles number of mining machines on order
Enterprise-scale cryptocurrency mining company Argo Blockchain has amended and expanded its existing order for mining equipment from supplier Bitmain, it announced on Wednesday.
Serco signs £800m contract with MoJ
Serco has signed a 10-year, £800m contract with the UK Ministry of Justice (MoJ) to provide prisoner escort and custody services for the South of England.
German jobs market cools in October, adding to calls for fiscal stimulus
German unemployment rose only slightly more quickly than expected in October as the country's economy fell into a recession, but some economists said that might be enough to push policymakers to enact fiscal stimulus.
Fiat Chrysler and Peugeot parent PSA confirm merger talks
Fiat Chrysler and Peugeot owner PSA Group confirmed on Wednesday that they are in merger talks.
Deutsche Bank posts bigger-than-expected loss amid restructuring
Deutsche Bank reported a bigger-than-expected third-quarter loss on Wednesday as it took a hit from restructuring costs.
Credit Suisse pleased with third quarter performance in 'challenging' environment
Credit Suisse reported a 70% improvement in group pre-tax income in its third quarter results on Wednesday, to CHF 1. 1bn (£0. 86bn), while group net income rose 108% year-on-year to CHF 881m.
Riverstone Energy seeks to diversify amid 'challenging' E&P market
Riverstone Energy updated the market on its performance for the three months ended 30 September on Wednesday, reporting a net asset value of $782m or £636m at period end, making for a net asset value per share of $9. 79 or £7. 97.
Dechra Pharmaceuticals appoints Paul Sandland as permanent CFO
Dechra Pharmaceuticals on Wednesday appointed Paul Sandland as an executive director and permanent chief financial officer with immediate effect.
ConvaTec wraps up solid third quarter performance
Medical products and technologies company ConvaTec Group updated the market on its trading for the third quarter on Wednesday, reporting that it was in line with management expectations, with full-year guidance remaining unchanged.